Business

BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026

SUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and report its financial results for the first quarter of 2026 by conference call on Friday, May 15, 2026 at 4:30 PM EDT. Following management’s formal remarks, there will be a question-and-answer session. Participants can register for the conference

articleBiocardia, Inc.May 11, 20262/company/biocardia-inc/news/biocardia-to-host-q1-2026-financial-results-and-corporate-update-conference-call-on-may-15-2026
BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026

About this update from Biocardia, Inc.

[{"type":"image","alt":"BioCardia, Inc.","displaySize":"","headline":null,"caption":"BioCardia, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":68,"url":"https://media.zenfs.com/en/globenewswire.com/a5e6da8ba4e1db953fe3f1e134f34300"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/9LRmPDXaunp8hOvXtHE3kg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTk1/https://media.zenfs.com/en/globenewswire.com/a5e6da8ba4e1db953fe3f1e134f34300","width":300,"height":68},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/9LRmPDXaunp8hOvXtHE3kg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTk1/https://media.zenfs.com/en/globenewswire.com/a5e6da8ba4e1db953fe3f1e134f34300","width":300,"height":68}},"lazy":false},{"type":"text","content":"SUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and report its financial results for the first quarter of 2026 by conference call on Friday, May 15, 2026 at 4:30 PM EDT. Following management’s formal remarks, there will be a question-and-answer session.","length":454,"tagName":"p"},{"type":"text","content":"Participants can register for the conference by navigating to: https://dpregister.com/sreg/10209272/104069d5d88.","length":112,"tagName":"p"},{"type":"text","content":"Please note that registered participants will receive their dial-in number upon registration. For those who have not registered, to listen to the call by phone, interested parties within the U.S. should call 1-833-316-0559 and international callers should call 1-412-317-5730. All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to join the BioCardia call. The conference call will also be available through a live webcast, which can be accessed through the following link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=Rt7kKGAp.","length":588,"tagName":"p"},{"type":"text","content":"A webcast replay of the call will be available approximately one hour after the end of the call through approximately August 15, 2026 at the following link: https://services.choruscall.com/ccforms/replay.html. A telephonic replay of the call will also be available and may be accessed by calling 1-855-669-9658 (toll fre...

More updates from Biocardia, Inc.

BioCardia®, Inc.pulmonary diseasesBioCardiaconference callBioCardia, Inc.international callers